GGrantIndex
Sort

326,823 grants matching clinical trial

Development of Rectal Enema As Microbicide (DREAM)

$4,612,049
Craig Walter Hendrix · Johns Hopkins University · U19 · FY2016 · AI

Cancer Center Support Grant

$4,611,074
Timothy J Eberlein · Washington University · P30 · FY2010 · CA

Children's Oncology Group NCORP Research Base

$4,610,801
Brad H. Pollock · Children'S Hosp Of Philadelphia · UG1 · FY2019 · CA

Clinical & Research Informatics

$4,610,151
Constantine A. Stratakis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIH · FY2015 · HD

Core-002

$4,610,041
Gloria David · Rho Federal Systems Division, Inc. · UM2 · FY2022 · AI

OUTLAST - A First Multiple-Dose Efficacy Study of IXT-m200, an anti-METH Monoclonal Antibody, in Patients with METH Use Disorder

$4,609,902
Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2023 · DA

SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER

$4,606,727
Michael Leo Leblanc · Fred Hutchinson Cancer Research Center · U10 · FY2012 · CA

Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant

$4,604,595
Michael E. Roth · Public Health Institute · UG1 · FY2025 · CA

ACTIVE MIND: An adaptive clinical trial of cognitive training to improve function and delay dementia

$4,604,476
Jennifer Lee O'Brien · University Of South Florida · R01 · FY2023 · AG

SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER

$4,603,957
John J Crowley · Fred Hutchinson Cancer Research Center · U10 · FY2011 · CA

Northwestern University Clinical and Translational Science Institute (NUCATS)

$4,602,173
Donald M Lloyd-Jones · Northwestern University At Chicago · UL1 · FY2017 · TR

Epidemiology of Diabetes Interventions and Complications (EDIC)

$4,600,077
Rose A Gubitosi-Klug · Case Western Reserve University · U01 · FY2013 · DK

Laboratory Center (LC): Microbicide Trials Network

$4,599,130
Charlene Dezzutti · Magee-Women'S Res Inst And Foundation · UM1 · FY2017 · AI

OUTLAST - A First Multiple-Dose Efficacy Study of IXT-m200, an anti-METH Monoclonal Antibody, in Patients with METH Use Disorder

$4,597,509
Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2021 · DA

Hormone-Related Cancers

$4,595,689
Louise Brinton · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA

Development of Therapeutic Products for Biodefense, AntiMicrobial Resistant (AMR) Infections and Emerging Infectious Diseases

$4,595,632
Urs Oschner · Crestone, Inc. · N01 · FY2024 · AI

Office of the Clinical Director

$4,595,305
Maryland Pao · National Institute Of Mental Health · ZID · FY2012 · MH

Arylepoxamides: A new class of potent, safer analgesics

$4,595,217
Jeffrey Reich · Sparian Biosciences, Inc. · UH3 · FY2021 · DA

Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit

$4,594,591
Jeffrey S Stringer · University Of Alabama At Birmingham · U01 · FY2008 · AI

Cancer Center Support Grant

$4,593,451
Michelle M Le Beau · University Of Chicago · P30 · FY2018 · CA

The Moderate Alcohol and Cardiovascular Health Trial

$4,593,295
Kenneth Jay Mukamal · Beth Israel Deaconess Medical Center · U10 · FY2017 · AA

Collaboratory of AIDS Researchers for Eradication (CARE)

$4,592,950
David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2016 · AI

Collaboratory of AIDS Researchers for Eradication (CARE)

$4,592,950
David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2018 · AI

Collaboratory of AIDS Researchers for Eradication (CARE)

$4,592,950
David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2017 · AI

Collaboratory of AIDS Researchers for Eradication (CARE)

$4,592,950
David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2020 · AI